Ingevity Corp(NGVT)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #1,410 of 2,960 stocksTOP 50%
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
NGVT Stock Analysis & AI Quality Score
Data updated 2026-07-26AI stock analysis and institutional research for Ingevity Corp (NGVT), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores NGVT at 53.1/100 on a 32-signal composite quality model, placing it at rank #1,410 of 2,960 stocks — the top half of the AI-ranked universe. NGVT scores in the top quartile across earnings quality (92.4). Areas of concern include revenue growth (20.4) and institutional flow (20.8), which score below median versus the broader universe. Shareholder dilution risk is elevated at 45.1/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Ingevity Corp reports quarterly revenue of $314.1M, net income of $35.3M, free cash flow of $-24.1M. Top institutional holders of NGVT by reported 13-F value include BlackRock, VANGUARD PORTFOLIO MANAGEMENT, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. NGVT trades on the NYSE exchange and files with the SEC under CIK 1653477. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NGVT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Ingevity Corp directly from SEC EDGAR.
Revenue
Q2 2026
$314.1M
Net Income
Q2 2026
$35.3M
Free Cash Flow
Q2 2026
$-24.1M
ROIC
Q2 2026
16.3%
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
-2.7% YoYNet Income
+61.2% YoYOperating Income
-1.7% YoYEPS (Diluted)
+61.1% YoYTotal Assets
-18.4% YoYTotal Debt
-13.7% YoYOp. Cash Flow
+157.5% YoYFree Cash Flow
+436.3% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $1.17B -2.7% | $1.20B -1.3% | $1.22B -27.1% | $1.67B +19.9% | $1.39B +14.4% | $1.22B |
| Net Income | $-167.1M +61.2% | $-430.3M -7868.5% | $-5.4M -102.6% | $211.6M +79.2% | $118.1M -34.9% | $181.4M |
| Operating Income | $418.7M -1.7% | $425.9M +0.6% | $423.2M -6.5% | $452.6M +7.2% | $422.2M +6.1% | $397.9M |
| EPS (Diluted) | $-4.61 +61.1% | $-11.85 -7800.0% | $-0.15 -102.7% | $5.50 +86.4% | $2.95 -32.5% | $4.37 |
| Total Assets | $1.65B -18.4% | $2.02B -22.9% | $2.62B -4.1% | $2.74B +10.8% | $2.47B +5.8% | $2.33B |
| Total Debt | $1.21B -13.7% | $1.40B -4.5% | $1.47B -0.4% | $1.47B +16.1% | $1.27B -2.8% | $1.31B |
| Operating Cash Flow | $331.2M +157.5% | $128.6M -37.3% | $205.1M -34.6% | $313.4M +6.9% | $293.3M -16.8% | $352.4M |
| Free Cash Flow | $273.5M +436.3% | $51.0M -46.5% | $95.3M -44.2% | $170.9M -9.8% | $189.5M -29.9% | $270.3M |
Get alerted when NGVT's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Ingevity Corp including:
Top Institutional Holders of NGVT
BlackRock, Inc.
$400.5M5,364,204 shVANGUARD PORTFOLIO MANAGEMENT LLC
$177.5M2,376,803 shVANGUARD CAPITAL MANAGEMENT LLC
$117.3M1,571,127 shSTATE STREET CORP
$111.8M1,497,321 shAMERICAN CENTURY COMPANIES INC
$94.9M1,270,958 shWELLINGTON MANAGEMENT GROUP LLP
$80.3M1,075,514 shSEGALL BRYANT & HAMILL, LLC
$78.7M1,054,605 shMILLENNIUM MANAGEMENT LLC
$74.1M992,049 shBROWN ADVISORY INC
$72.7M974,107 shROYCE & ASSOCIATES LP
$70.2M940,417 sh
| Fund | Value | Shares |
|---|---|---|
| BlackRock, Inc. | $400.5M | 5,364,204 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $177.5M | 2,376,803 |
| VANGUARD CAPITAL MANAGEMENT LLC | $117.3M | 1,571,127 |
| STATE STREET CORP | $111.8M | 1,497,321 |
| AMERICAN CENTURY COMPANIES INC | $94.9M | 1,270,958 |
| WELLINGTON MANAGEMENT GROUP LLP | $80.3M | 1,075,514 |
| SEGALL BRYANT & HAMILL, LLC | $78.7M | 1,054,605 |
| MILLENNIUM MANAGEMENT LLC | $74.1M | 992,049 |
| BROWN ADVISORY INC | $72.7M | 974,107 |
| ROYCE & ASSOCIATES LP | $70.2M | 940,417 |
Companies Similar to NGVT
Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.
Pediatrix Medical Group, Inc.
Prestige Consumer Healthcare Inc.
ICU MEDICAL INC/DE
ZIMMER BIOMET HOLDINGS, INC.
ALIGN TECHNOLOGY INC
Envista Holdings Corp
U S PHYSICAL THERAPY INC /NV
Chemours Co
Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.
More Healthcare Companies
View all Healthcare →Put NGVT on your watchlist
Track score changes the day Ingevity Corp files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is NGVT a good stock to buy?
13F Pro's AI-powered analysis of Ingevity Corp (NGVT) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for NGVT are available on the NGVT stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. NGVT is classified as a mid company.
Which hedge funds own NGVT?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling NGVT. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Ingevity Corp's investment landscape.